By Jimoh Babatunde

The Chief Executive Officer, CEO, of Medbury Healthcare Group, Dr. Itunu Akinware, has emphasised the Centre’s commitment to responsible innovation that aligned with strong clinical standards and patient safety.
She spoke at the Regenerative Medicine Clinic Conference organized by Medlyfe Wellness and Regenerative Medicine Centre, a subsidiary of Medbury Healthcare Group, with the theme “Shaping the Future of Medicine,” held at Four Points by Sheraton, Victoria Island, recently.
Akinware said the theme of the conference focused on positioning Nigeria as a rising hub for responsible regenerative medicine, longevity science, biobanking infrastructure development, and ethical clinical governance.
“The future of medicine lies in innovation that is evidence-based, ethically governed, and capable of transforming patient care. This conference reflects our dedication to bringing global expertise to Nigeria while strengthening local clinical capacity,” she said.
Dr. Akinware added that regenerative and longevity medicine represent a critical frontier for healthcare delivery that must be developed deliberately and in harmony with national healthcare priorities.
Also speaking at the event, the Head of Medical Services at Medlyfe, Dr. Adedotun Ajelabi, reiterated the Centre’s role as both a clinical provider and a convener of key stakeholders in shaping how innovation integrates into mainstream healthcare delivery.
“Our responsibility extends beyond clinical care to guiding how emerging therapies enter and adapt within our healthcare system,” Dr. Ajelabi said.
 “By bringing global and local experts together, we are nurturing an environment where regenerative and longevity medicine can thrive ethically and safely.”
Dr. Veerapol Khemarangsann and Mr. Piyawat Ratchapolsitte, representatives of the Medeze Group, a Thailand-based biotechnology and biobanking leader, participated in strategic discussions exploring potential partnerships and expansion into the Nigerian healthcare market.
During their presentations, the Thai delegates shared global best practices for cell banking and biobanking ecosystems, clinical and economic applications of regenerative therapies, and sustainable models for healthcare infrastructure in emerging economies.
They also highlighted the growing importance of biotechnology in longevity science and its future clinical applications.
A major highlight of the event was a detailed session by Dr. Chris Paulus, Executive Director of the American Board of Regenerative Medicine, who outlined international benchmarks for regenerative practice.
Dr. Paulus stressed the importance of ethical, evidence-based clinical standards
physician credentialing and training pathways; Clear differentiation between regulated therapies and unproven interventions and Governance and professional accountability frameworks
His remarks underscored the urgency for Nigeria to harmonise its regenerative medicine ecosystem with globally recognised standards as the field evolves.
In a message to conference delegates, Lagos State Commissioner for Health, Prof. Akin Abayomi, praised the initiative and reaffirmed the state’s support for healthcare innovation.
“Lagos State recognises the importance of innovation in healthcare, particularly in emerging fields like regenerative and preventive medicine. Platforms such as this are vital for knowledge exchange, capacity building, and ensuring that new medical frontiers develop within robust regulatory frameworks,” Prof. Abayomi said.
He further emphasised the need for constructive engagement between private healthcare players and public regulators to elevate the quality of care and future-ready services across the state.
The conference concluded with a multispecialty roundtable that explored cross-border collaboration, physician training, referral pathways, and regulatory ecosystem development.
 Medlyfe Wellness announced plans to continue working closely with global partners, regulators, and healthcare leaders to support growth in regenerative medicine and longevity science in Nigeria.